Should You Buy Intuitive Surgical Stock While It's Under $500?

Core Viewpoint - Intuitive Surgical is positioned as a promising healthcare company with significant growth potential, particularly through its da Vinci surgical systems, which enhance surgical precision and patient outcomes [1][3]. Company Performance - Intuitive Surgical has demonstrated strong revenue growth, with a 19% increase in revenue during the fourth quarter of 2025, totaling just under $2.9 billion, marking an acceleration from previous years [2]. - The company has consistently grown its top line by double digits over the years, indicating a robust growth trajectory [2]. Market Potential - The robotic-assisted surgery market is still in its early growth stages, suggesting that Intuitive Surgical has substantial room for future expansion, making it an attractive long-term investment [3]. Valuation Metrics - Intuitive Surgical's stock is currently trading at less than $500, with a price-to-earnings multiple exceeding 60, and a forward multiple of around 50 based on analyst projections, indicating high expectations for future growth [4]. - In comparison, the average stock on the S&P 500 trades at 25 times trailing earnings and 22 times future earnings, highlighting the premium valuation of Intuitive Surgical [4]. Investment Outlook - While the stock may not be considered a bargain at its current valuation, it holds potential as a long-term investment, provided investors are willing to hold for several years to realize growth [5][6]. - The high valuation could expose the stock to further declines, particularly in the event of a market correction, but it remains a viable growth stock for long-term investors [6].